Section 1e: Version 3 (V3)
Section 2: Clinical and Administrative Domains
HL7 Version 3 Standard: Study Design: Structured Document, Release 1 - US Realm
DESCRIPTION
A structured document capable of exchanging the human-readable text (i.e. the traditional text-based protocol document currently provided as either a paper document, or a pdf file) in addition to structured protocol data. Some of the requirements for this structured document cannot be met by CDA and therefore this will be a unique structure developed as a sibling to CDA
ALTERNATIVE NAMES
HL7 Version 3 Standard: Study Design: Structured Document, Release 1 - US Realm may also go by the following names or acronyms:
"HL7 V3 Standard: Study Design: Structured Document, R1"
TARGETS
- FDA
- Various Pharmaceutical companies
BENEFITS
- Provides a means of communicating a clinical research study protocol in both human readable form and processable data for the design items of the protocol
IMPLEMENTATIONS/CASE STUDIES
- FDA
- Various Pharmaceutical companies
RELATED DOCUMENTS
![]() |
HL7 Version 3 Standard: Study Design: Structured Document, Release 1 - US Realm |
TOPIC
- Regulated Studies
BALLOT TYPE
- DSTU
STATUS DATE
2016-03-16RESPONSIBLE WORK GROUP
FAMILY
- V3
CURRENT STATE
- Retired
REALM
- US Realm